Le Lézard
Classified in: Business
Subject: DIV

Stellus Capital Investment Corporation Declares Second Quarter 2020 Regular Dividend of $0.25 Per Share


HOUSTON, July 1, 2020 /PRNewswire/ -- Stellus Capital Investment Corporation (the "Company") (NYSE: SCM) announced that yesterday its Board of Directors has declared a regular quarterly dividend for the second quarter of 2020 of $0.25 per share. As previously reported, the Company has changed the frequency of dividend payments from monthly to quarterly. "In light of the lower interest rate environment the Company is experiencing, we believe a dividend of $0.25 per share is appropriate for the second quarter. For the third quarter of 2020, we expect to declare the dividend by September 30th", said Robert T. Ladd, Chief Executive Officer of the Company.

Second Quarter 2020 Regular Quarterly Dividend

Declared

Ex-Dividend Date

Record Date

Payment Date

Amount per Share

6/30/20

7/14/20

7/15/20

7/31/20

$0.2500

About Stellus Capital Investment Corporation

The Company is an externally-managed, closed-end, non-diversified investment management company that has elected to be regulated as a business development company under the Investment Company Act of 1940. The Company's investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation by investing primarily in private middle-market companies (typically those with $5.0 million to $50.0 million of EBITDA (earnings before interest, taxes, depreciation and amortization)) through first lien, second lien, unitranche and mezzanine debt financing, and corresponding equity investments. The Company's investment activities are managed by its investment adviser, Stellus Capital Management. To learn more about Stellus Capital Investment Corporation, visit www.stelluscapital.com under the "Public Investors" link.

FORWARD-LOOKING STATEMENTS

Statements included herein may contain "forward-looking statements" which relate to future performance or financial condition. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of assumptions, risks and uncertainties, which change over time. Actual results may differ materially from those anticipated in any forward-looking statements as a result of a number of factors, including those described from time to time in filings by the Company with the Securities and Exchange Commission including the final prospectus that will be filed with the Securities and Exchange Commission. The Company undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.

Contacts 
Stellus Capital Investment Corporation 
W. Todd Huskinson, (713) 292-5414 
Chief Financial Officer 
thuskinson@stelluscapital.com

 

SOURCE Stellus Capital Investment Corporation


These press releases may also interest you

at 21:50
Algernon Pharmaceuticals Inc. ("Algernon" or "Company") , a clinical stage pharmaceutical development company, announces that it has extended 4,000,000 warrants originally expiring on July 18, 2020 (the "Warrants").  The Company has extended the...

at 21:43
Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") today announced the pricing of its upsized public offering of 6,000,000 shares of the Company's common stock at a price of $160.50 per share in connection with the forward sale...

at 21:19
Great-West Lifeco Inc. (Lifeco) announced today that it has entered into an agreement with a syndicate of agents co-led by RBC Capital Markets, BMO Capital Markets and Scotiabank for the sale on an agency basis of $250 million aggregate principal...

at 21:00
Olymp Trade has announced an introduction of a service levels system. It is a kind of ecosystem of trader development. In the first iteration, the company traders will receive Starter, Advanced, or Expert statuses....

at 20:46
Pomerantz LLP is investigating claims on behalf of investors of  DXC Technology Company ("DXC" or the "Company") .   Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 7980. The investigation...

at 20:36
Pomerantz LLP announces that a class action lawsuit has been filed against Chembio Diagnostics, Inc. ("Chembio" or the "Company") and certain of its officers.   The class action, filed in United States District Court for the Eastern District of New...



News published on 1 july 2020 at 06:00 and distributed by: